Morgan Welch Inflammatory Breast Cancer Clinic and Research Program,
Department of Radiation Oncology
Wendy A. Woodward has not added Biography.
If you are Wendy A. Woodward and would like to personalize this page please email our Author Liaison for assistance.
On mammary stem cells.
Journal of cell science Aug, 2005 | Pubmed ID: 16105882
Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.
International journal of radiation oncology, biology, physics Mar, 2009 | Pubmed ID: 18707822
Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2008 | Pubmed ID: 18725647
Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions.
International journal of radiation oncology, biology, physics Mar, 2010 | Pubmed ID: 20159363
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.
Molecular cancer Jul, 2010 | Pubmed ID: 20615238
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
PloS one , 2010 | Pubmed ID: 20808935
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
Breast cancer research and treatment Feb, 2011 | Pubmed ID: 21153052
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.
European journal of cancer (Oxford, England : 1990) Jul, 2011 | Pubmed ID: 21334874
Have we made progress in inflammatory breast cancer? Not so fast.
Oncology (Williston Park, N.Y.) Mar, 2011 | Pubmed ID: 21548471
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.
Clinical breast cancer Oct, 2011 | Pubmed ID: 21764391
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.
The oncologist , 2011 | Pubmed ID: 22147002
Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.
Cancer Oct, 2012 | Pubmed ID: 22511276
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Breast cancer research and treatment Jul, 2012 | Pubmed ID: 22547109
Inflammatory breast cancer: what we know and what we need to learn.
The oncologist , 2012 | Pubmed ID: 22584436
Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.
Stem cells (Dayton, Ohio) Nov, 2012 | Pubmed ID: 22961641
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2013 | Pubmed ID: 23396049
Genomic and expression analysis of microdissected inflammatory breast cancer.
Breast cancer research and treatment Apr, 2013 | Pubmed ID: 23568481
Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
American journal of clinical oncology Jun, 2015 | Pubmed ID: 23648437
Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.
Breast cancer research : BCR , 2013 | Pubmed ID: 24008095
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
PloS one , 2013 | Pubmed ID: 24013655
TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
Cancer research Nov, 2013 | Pubmed ID: 24014597
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
Breast cancer research : BCR Nov, 2013 | Pubmed ID: 24274653
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.
PloS one , 2013 | Pubmed ID: 24312594
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
PloS one , 2014 | Pubmed ID: 24416156
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.
Cancer May, 2014 | Pubmed ID: 24510381
Statistical modeling approach to quantitative analysis of interobserver variability in breast contouring.
International journal of radiation oncology, biology, physics May, 2014 | Pubmed ID: 24613812
Current clinical coverage of Radiation Therapy Oncology Group-defined target volumes for postmastectomy radiation therapy.
Practical radiation oncology Jul-Sep, 2012 | Pubmed ID: 24674124
Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.
SpringerPlus , 2014 | Pubmed ID: 24711988
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Stem cells translational medicine Jul, 2014 | Pubmed ID: 24833589
Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?
Annals of surgical oncology Aug, 2014 | Pubmed ID: 24841348
Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla.
Practical radiation oncology Mar-Apr, 2014 | Pubmed ID: 24890352
Postmastectomy radiation therapy for inflammatory breast cancer: is more better?
International journal of radiation oncology, biology, physics Aug, 2014 | Pubmed ID: 25035202
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
Journal of experimental & clinical cancer research : CR Jul, 2014 | Pubmed ID: 25051981
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Nature cell biology Sep, 2014 | Pubmed ID: 25086746
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
Nature communications Dec, 2014 | Pubmed ID: 25476932
Circulating tumor cells in newly diagnosed inflammatory breast cancer.
Breast cancer research : BCR Jan, 2015 | Pubmed ID: 25572591
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.
SpringerPlus , 2015 | Pubmed ID: 25674496
Should Surgery Referral be Standard Practice in Metastatic Inflammatory Breast Cancer?
Annals of surgical oncology Aug, 2015 | Pubmed ID: 25794829
Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.
Practical radiation oncology Jul-Aug, 2015 | Pubmed ID: 25804105
Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
PloS one , 2015 | Pubmed ID: 25807360
High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer.
International journal of radiation oncology, biology, physics Apr, 2015 | Pubmed ID: 25832697
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Breast cancer research : BCR Mar, 2015 | Pubmed ID: 25887413
Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment.
International journal of radiation oncology, biology, physics Jul, 2015 | Pubmed ID: 25892584
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Breast cancer research and treatment Jul, 2015 | Pubmed ID: 26017070
Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Breast cancer research and treatment Jul, 2015 | Pubmed ID: 26092296
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
PloS one , 2015 | Pubmed ID: 26207636
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
JAMA oncology Oct, 2015 | Pubmed ID: 26247543
Breast Radiation Therapy--Sometimes Less May Be More.
International journal of radiation oncology, biology, physics Sep, 2015 | Pubmed ID: 26279015
Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.
International journal of radiation oncology, biology, physics Sep, 2015 | Pubmed ID: 26279028
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.
PloS one , 2015 | Pubmed ID: 26317219
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
Cancer Dec, 2015 | Pubmed ID: 26348887
Breast Cancer Stem Cell Correlates as Predicative Factors for Radiation Therapy.
Seminars in radiation oncology Oct, 2015 | Pubmed ID: 26384273
Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Nov, 2015 | Pubmed ID: 26482599
Inflammatory breast cancer: unique biological and therapeutic considerations.
The Lancet. Oncology Nov, 2015 | Pubmed ID: 26545845
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
Breast cancer research and treatment Dec, 2015 | Pubmed ID: 26590814
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.
Breast cancer research : BCR Dec, 2015 | Pubmed ID: 26643555
Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology.
Journal of the American College of Radiology : JACR Apr, 2016 | Pubmed ID: 26681164
Epidemiological risk factors associated with inflammatory breast cancer subtypes.
Cancer causes & control : CCC Mar, 2016 | Pubmed ID: 26797453
MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.
International journal of radiation oncology, biology, physics 06, 2016 | Pubmed ID: 27055396
miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
Journal of the National Cancer Institute Aug, 2016 | Pubmed ID: 27075851
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.
Oncotarget May, 2016 | Pubmed ID: 27078845
Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.
BioMed research international , 2016 | Pubmed ID: 27195300
Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.
Cancer 09, 2016 | Pubmed ID: 27305037
Cancer Stem Cells.
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer , 2016 | Pubmed ID: 27318680
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.
Oncotarget May, 2017 | Pubmed ID: 27374101
Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response.
International journal of radiation oncology, biology, physics 09, 2016 | Pubmed ID: 27511855
Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
Annals of surgery 03, 2017 | Pubmed ID: 27735826
Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Oncotarget Dec, 2016 | Pubmed ID: 27756885
Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer.
Cancer Jul, 2017 | Pubmed ID: 28295213
Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.
The Lancet. Oncology 04, 2017 | Pubmed ID: 28368261
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
Breast cancer research and treatment Jul, 2017 | Pubmed ID: 28417335
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.
Breast cancer research : BCR 04, 2017 | Pubmed ID: 28424080
Inflammatory breast cancer: a model for investigating cluster-based dissemination.
NPJ breast cancer , 2017 | Pubmed ID: 28649661
Novel therapeutic strategies in the treatment of triple-negative breast cancer.
Therapeutic advances in medical oncology Jul, 2017 | Pubmed ID: 28717401
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
International journal of radiation oncology, biology, physics 08, 2017 | Pubmed ID: 28721885
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival.
Journal of Cancer , 2017 | Pubmed ID: 28819368
A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.
International journal of radiation oncology, biology, physics 11, 2017 | Pubmed ID: 28843370
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.
Oncotarget Sep, 2017 | Pubmed ID: 28978083
Effect of statins on breast cancer recurrence and mortality: a review.
Breast cancer (Dove Medical Press) , 2017 | Pubmed ID: 29238220
Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
International journal of radiation oncology, biology, physics 01, 2018 | Pubmed ID: 29254776
Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
International journal of radiation oncology, biology, physics 03, 2018 | Pubmed ID: 29485045
Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 05, 2018 | Pubmed ID: 29558281
Development of CNS metastases and survival in patients with inflammatory breast cancer.
Cancer 06, 2018 | Pubmed ID: 29579338
Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
PloS one , 2018 | Pubmed ID: 29617367
Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects.
Cancers Apr, 2018 | Pubmed ID: 29642467
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference.
Journal of Cancer , 2017 | Pubmed ID: 29667990
Inflammatory breast cancer biology: the tumour microenvironment is key.
Nature reviews. Cancer 08, 2018 | Pubmed ID: 29703913
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.
Journal of Cancer , 2018 | Pubmed ID: 29721054
Reply to 'A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18'.
Breast (Edinburgh, Scotland) 06, 2018 | Pubmed ID: 29729725
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.
Cancer letters 09, 2018 | Pubmed ID: 29746927
Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key.
Nature reviews. Cancer Aug, 2018 | Pubmed ID: 29748602
Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
Breast cancer research and treatment Sep, 2018 | Pubmed ID: 29858753
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer.
JAMA oncology 09, 2018 | Pubmed ID: 29879283
Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
International journal of radiation oncology, biology, physics 11, 2018 | Pubmed ID: 29928946
Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
The Surgical clinics of North America Aug, 2018 | Pubmed ID: 30005774
Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer.
Frontiers in oncology , 2018 | Pubmed ID: 30023340
Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA oncology 12, 2018 | Pubmed ID: 30027292
Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.
Practical radiation oncology Jan, 2019 | Pubmed ID: 30125673
A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.
Advances in radiation oncology Jul-Sep, 2018 | Pubmed ID: 30197937
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
PloS one , 2018 | Pubmed ID: 30248155
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
PloS one , 2018 | Pubmed ID: 30312311
Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO-AACR Research Workshop.
Clinical cancer research : an official journal of the American Association for Cancer Research 05, 2019 | Pubmed ID: 30723144
Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.
The oncologist 10, 2019 | Pubmed ID: 30952823
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.
Cancer immunology research 06, 2019 | Pubmed ID: 31043414
Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.
Breast cancer research and treatment Aug, 2019 | Pubmed ID: 31054033
Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.
Practical radiation oncology Nov, 2019 | Pubmed ID: 31132433
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.
Journal of Cancer , 2019 | Pubmed ID: 31258771
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.
International journal of radiation oncology, biology, physics 11, 2019 | Pubmed ID: 31381960
Building momentum for subsets of patients with advanced triple-negative breast cancer.
The Lancet. Oncology 01, 2020 | Pubmed ID: 31786122
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
JAMA oncology 04, 2020 | Pubmed ID: 31917424
Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials.
The oncologist 06, 2020 | Pubmed ID: 32272505
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
BMC cancer May, 2020 | Pubmed ID: 32423453
Molecular Predictive and Prognostic Markers in Locoregional Management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 07, 2020 | Pubmed ID: 32442060
IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.
Toxicology and applied pharmacology 08, 2020 | Pubmed ID: 32512068
In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.
Biotechnology and bioengineering Jul, 2020 | Pubmed ID: 32648934
Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center.
Advances in radiation oncology Jul-Aug, 2020 | Pubmed ID: 32775771
Understanding the Intersection of Working from Home and Burnout to Optimize Post-COVID19 Work Arrangements in Radiation Oncology.
International journal of radiation oncology, biology, physics Oct, 2020 | Pubmed ID: 32890515
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer.
Cancers Oct, 2020 | Pubmed ID: 33114311
NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.
Cancers Dec, 2020 | Pubmed ID: 33321961
Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer.
Journal of surgical oncology Dec, 2020 | Pubmed ID: 33333583
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer.
Communications biology Jan, 2021 | Pubmed ID: 33452400
Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum.
Translational oncology Jan, 2021 | Pubmed ID: 33535154
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados